86 related articles for article (PubMed ID: 15055047)
1. Enhanced portal flow velocity and volume following Iloprost treatment.
Zardi EM; Picardi A; Ambrosino G; Fazio VM; Dobrina A; Afeltra A; Frego M
Acta Biomed; 2003; 74 Suppl 2():108-10. PubMed ID: 15055047
[TBL] [Abstract][Full Text] [Related]
2. Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis.
Zardi EM; Picardi A; Ambrosino G; Fazio VM; Dobrina A; Frego M; Afeltra A; Lumachi F
In Vivo; 2006; 20(3):377-80. PubMed ID: 16724674
[TBL] [Abstract][Full Text] [Related]
3. Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications.
Zardi EM; Picardi A; Fazio VM; Ambrosino G; Dobrina A; Zullo M; Zennaro D; Afeltra A
J Interferon Cytokine Res; 2004 May; 24(5):297-300. PubMed ID: 15153313
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic effects of a prostacyclin analog (iloprost) on portal flow velocity and volume and visceral artery circulation in patients with lower limb arteriopathy.
Zardi EM; Picardi A; Ambrosino G; Serio A; Costantino S; Dobrina A
Ultrasound Med Biol; 2003 Feb; 29(2):209-13. PubMed ID: 12659908
[TBL] [Abstract][Full Text] [Related]
5. Clinical and circulatory effects of Iloprost either administered for 1 week or 4 weeks in patients with peripheral obstructive arterial disease at Leriche-Fontaine stage III.
Arosio E; Sardina M; Prior M; De Marchi S; Zannoni M; Bianchini C
Eur Rev Med Pharmacol Sci; 1998; 2(2):53-9. PubMed ID: 10229559
[TBL] [Abstract][Full Text] [Related]
6. [Quantitative evaluation of flow in the portal vein. Comparison of bolus tracking magnetic resonance and Doppler color ultrasound].
Manfredi R; Scarano E; Barbaro B; Prudenzano R; Marano P
Radiol Med; 1997 Dec; 94(6):626-31. PubMed ID: 9524601
[TBL] [Abstract][Full Text] [Related]
7. Trial of a novel prostacyclin analog, UT-15, in patients with severe intermittent claudication.
Mohler ER; Klugherz B; Goldman R; Kimmel SE; Wade M; Sehgal CM
Vasc Med; 2000; 5(4):231-7. PubMed ID: 11213235
[TBL] [Abstract][Full Text] [Related]
8. [Study of vascular access (VA) by color Doppler ultrasonography (CDU). Comparison between delta-H and CDU methods in measuring VA blood flow rate].
Roca-Tey R; Rivas A; Samon R; Ibrik O; Viladoms J
Nefrologia; 2005; 25(6):678-83. PubMed ID: 16514909
[TBL] [Abstract][Full Text] [Related]
9. [A clinical study on splanchnic hemodynamic changes after orthotopic liver transplantation for patients with portal hypertension].
Jiang SM; Zhou GW; Shen C; Yan JQ; Wan L; Li QY; Yang WP; Shen BY; Chen H; Peng CH; Li HW
Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(22):1699-702. PubMed ID: 19094727
[TBL] [Abstract][Full Text] [Related]
10. Acute improved hemodynamics following inhaled iloprost in chronic thromboembolic pulmonary hypertension.
Krug S; Hammerschmidt S; Pankau H; Wirtz H; Seyfarth HJ
Respiration; 2008; 76(2):154-9. PubMed ID: 17804899
[TBL] [Abstract][Full Text] [Related]
11. Effect of vardenafil, an inhibitor of phosphodiesterase-5, on portal haemodynamics in normal and cirrhotic liver -- results of a pilot study.
Deibert P; Schumacher YO; Ruecker G; Opitz OG; Blum HE; Rössle M; Kreisel W
Aliment Pharmacol Ther; 2006 Jan; 23(1):121-8. PubMed ID: 16393289
[TBL] [Abstract][Full Text] [Related]
12. Comparison between color Doppler cineloop- and conventional spectral Doppler-derived maximum velocity and flow in the umbilical vein.
Gerada M; Struijk PC; Stewart PA; Guerriero S; Melis GB; Wladimiroff JW
Ultrasound Obstet Gynecol; 2006 Aug; 28(2):156-61. PubMed ID: 16823891
[TBL] [Abstract][Full Text] [Related]
13. Liver transplant recipients with portal vein thrombosis: a single center retrospective study.
Tao YF; Teng F; Wang ZX; Guo WY; Shi XM; Wang GH; Ding GS; Fu ZR
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):34-9. PubMed ID: 19208512
[TBL] [Abstract][Full Text] [Related]
14. [A new infusion method for a prostacyclin analogue].
Pibiri L; Petruzzo P; Angius D; Ruiu G; Polo F; Rescigno A; Brotzu G
Minerva Cardioangiol; 1997 Dec; 45(12):621-5. PubMed ID: 9577128
[TBL] [Abstract][Full Text] [Related]
15. Microcirculation and tolerability following i.v. infusion of PGE1 and iloprost: a randomized cross-over study in patients with critical limb ischemia.
Schellong S; Altmann E; von Bilderling P; Rudofsky G; Waldhausen P; Rogatti W
Prostaglandins Leukot Essent Fatty Acids; 2004 Jun; 70(6):503-9. PubMed ID: 15120713
[TBL] [Abstract][Full Text] [Related]
16. Effect of Iloprost infusion on metabolism in critical limb ischemia, utilizing microdialysis. A pilot study.
Danielsson P; Metzsch C; Norgren L
Int Angiol; 2004 Sep; 23(3):259-62. PubMed ID: 15765041
[TBL] [Abstract][Full Text] [Related]
17. Six years' experience with prostaglandin I2 infusion in elective open repair of abdominal aortic aneurysm: a parallel group observational study in a tertiary referral vascular center.
Beirne C; Hynes N; Sultan S
Ann Vasc Surg; 2008 Nov; 22(6):750-5. PubMed ID: 18992665
[TBL] [Abstract][Full Text] [Related]
18. [Modification of some prothrombotic indices after treatment with iloprost in arterial disease patients].
Ferlito S; Bonomo T; Costa R; Di Salvo MM; Attanasio L; Finocchiaro PM; Condorelli M; Mazzone D
Minerva Cardioangiol; 1996 Dec; 44(12):645-8. PubMed ID: 9053818
[TBL] [Abstract][Full Text] [Related]
19. Hepato-splanchnic metabolic effects of the stable prostacyclin analogue iloprost in patients with septic shock.
Kiefer P; Tugtekin I; Wiedeck H; Bracht H; Vogt J; Wachter U; Weiss M; Altin C; Georgieff M; Radermacher P
Intensive Care Med; 2001 Jul; 27(7):1179-86. PubMed ID: 11534566
[TBL] [Abstract][Full Text] [Related]
20. [Conservative treatment of chronic obstructive arterial disease with iloprost and physical training: assessment of results in 5 years of a study with 360 patients].
Apperti M; Masella A; Sabia D; Verde I
Ann Ital Chir; 2003; 74(4):453-7. PubMed ID: 14971289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
